Skip to main content
Equibles
PFE logo

PFE · Pfizer Inc

Track PFE — free

Use PFE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$28.07 -0.38 (-1.34%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$162.16B
Shares
5.70B

PFE metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.45
Market cap
$162.16B

Price action

19 metrics
Price change (1W)
+1.8%
Price change (30D)
+5.2%
Price change (3M)
+9.3%
Price change (6M)
+5.2%
Price change (YTD)
+14.3%
Price change (1Y)
+15.9%
Trailing year
Price change (5Y)
-39.3%
52-week high
$29.02
52-week low
$23.60
Change from 52-week high
-2.0%
Change from 52-week low
+20.6%
Annualized volatility
23.9%
Beta
0.3
RSI (14D)
62.5
Price vs SMA 50
+9.5%
Price vs SMA 200
+8.7%
Avg volume (3M)
42.18M
Relative volume
0.6
Average dollar volume
$1.08B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
5.70B

Valuation

12 metrics
P / E (TTM)
37.4
Trailing earnings · reciprocal yield 2.7%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.5×
reciprocal yield 39.3%
P / book
1.9
reciprocal yield 52.5%
FCF yield
6.8%
TTM · current market cap
Buyback yield
0.0%
P / FCF
14.8
reciprocal yield 6.8%
P / operating cash flow
12.1
reciprocal yield 8.3%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
25.0×
reciprocal yield 4.0%
P / E historical average (5Y)
19.3×
reciprocal yield 5.2%
EV / revenue historical average (3Y)
3.5×
reciprocal yield 28.8%
EV / revenue historical average (5Y)
3.5×
reciprocal yield 28.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
6.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
$1.72
Dividend growth YoY
+0.6%
Dividend growth streak
5
Last ex-dividend
2026-07-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
73.2%
Operating margin
—
Trailing 12 months
Net margin
6.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$4.33B
Trailing 12 months
Diluted EPS (TTM)
$0.76
FCF margin
17.2%
Effective tax rate
-3.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+2.6%
Year over year
Net income growth YoY
-108.5%
Revenue (TTM)
$63.70B
Trailing 12 months
EPS growth YoY
-107.8%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-14.8%
Revenue CAGR (5Y)
+8.5%
EPS CAGR (3Y)
-37.1%
EPS CAGR (5Y)
-3.6%
FCF CAGR (3Y)
-29.6%
FCF CAGR (5Y)
-5.7%

Quality

14 metrics
Return on equity
5.1%
Return on assets
2.2%
Debt / equity
0.7
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
$10.98B
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$976.00M
Total assets
$201.13B
Total debt
$63.19B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.40B
Capital expenditures (TTM)
$2.42B
R&D (TTM)
$11.05B
SG&A (TTM)
$13.72B
Stock compensation (TTM)
$947.00M
R&D / revenue
17.3%
Stock compensation / revenue
1.5%

Ownership (13F)

3 metrics
13F filers
2,840
13F filer change QoQ
-138
Institutional ownership
70.1%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.88M
Insider-sentiment score
86 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 78003 CUSIP 717081103 13F (30d) 1081 filings 1030 filers Visit website Investor relations